The new company will develop novel therapies to benefit the body’s immune system Oxitope Pharma and Arxx Therapeutics have announced their merger to form Calluna […]
CSL Behring’s study reveals significant long-term benefits New data from CSL Behring’s HOPE-B study demonstrates that Hemgenix (etranacogene dezaparvovec-drlb) gene therapy provides sustained efficacy and […]
The progressive neurodegenerative disease is estimated to affect 24 million people globally Researchers from the University of British Columbia in Canada have revealed that a […]